Effects of phenolics on vascular endothelial function

Current Opinion in Lipidology

Volumn 14, Issue 1, 2003, Pages 21-27

  Duffy, Stephen J ^a,c   Vita, Joseph A ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Cardiovascular risk; Coronary artery disease; Endothelium; Flavonoids; Nitric oxide; Phenols; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; APIGENIN; CATECHIN; DAIDZEIN; DIOSMETIN; ESTRADIOL; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GENISTEIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; NITRIC OXIDE; PHENOL DERIVATIVE; PROANTHOCYANIDIN DERIVATIVE; QUERCETIN; TRACE ELEMENT;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FOOD INTAKE; HUMAN; PRIORITY JOURNAL; REVIEW; TEA; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; PHENOL; TEA; TOCOPHEROLS; WINE;

EID: 0037312814     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200302000-00005     Document Type: Review

References (68)

1. Diaz MN, Frei B, Vita JA, et al. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-416.
2. Mashima R, Witting PK, Stocker R. Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol 2001; 12:411-418. A useful recent review of oxidative stress in atherosclerosis.
3. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354:447-455.
4. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:154-160.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:23-33.
6. Kromhout D, Menotti A, Kesteloot H, et al. Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation 2002; 105:893-898.
7. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342:1007-1011.
8. Mukamal KJ, Maclure M, Muller JE, et al. Tea consumption and mortality after acute myocardial infarction. Circulation 2002; 105:2476-2481.
9. Geleijnse JM, Launer LJ, Van der Kuip DA, et al. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002; 75:880-6.
10. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992; 339:1523-6.
11. Rimm EB, Stampfer MJ. Wine, beer, and spirits: are they really horses of a different color? Circulation. 2002; 105:2806-7.
12. Hertog MG, Hollman PC, Katan MB, et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993; 20:21-29.
13. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids [published erratum appears in Free Radic Biol Med 1996; 21(3):417]. Free Radic Biol Med. 1996; 20:933-956.
14. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56:317-333.
15. Halliwell B, Gutteridge JMC. Antioxidant defences. In: Halliwell B, Gutteridge JMC, editors. Free radicals in biology and medicine, 3rd ed. Oxford: Oxford University Press; 1999. pp. 105-245.
16. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52:673-751.
17. Duffy SJ, Vita JA, Keaney JK Jr. Antioxidants and endothelial function. Heart Failure. 1999; 15:135-152.
18. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
19. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81:491-497.
20. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 2002; 106:640-642.
21. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-1906.
22. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104:191-196. Demonstrated that forearm resistance vessel endothelial function predicts prognosis.
23. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002; 105:1567-1572. Demonstrated that brachial artery endothelial function predicts prognosis.
24. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol 2002; 13:41-49. A useful recent review of this topic.
25. Arts IC, Hollman PC, Feskens EJ, et al. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001; 74:227-232.
26. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001; 154:495-503.
27. Duffy SJ, Keaney JF Jr, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001; 104:151-156. The first study to demonstrate that tea reverses endothelial dysfunction in patients with coronary artery disease.
28. Hodgson JM, Puddey IB, Burke V, et al. Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 2002; 102:195-201. This study also demonstrated a beneficial effect of black tea on endothelial function.
29. Fitzpatrick DF, Hirschfield SL, Ricci T, et al. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 1995; 26:90-95.
30. Andriambeloson E, Kleschyov AL, Muller B, et al. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 1997; 120:1053-1058.
31. Hodgson JM, Croft KD, Mori TA, et al. Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 2002; 132:55-58.
32. Leenen R, Roodenburg AJ, Tijburg LB, et al. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 2000; 54:87-92.
33. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998; 18:833-841.
34. O'Reilly JD, Mallet AI, McAnlis GT, et al. Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 2001; 73:1040-1044.
35. Huang A, Vita JA, Venema RC, et al. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000; 275:17399-17406.
36. Di Castelnuovo A, Rotondo S, lacoviello L, et al. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002; 105:2836-2844.
37. Stein JH, Keevil JG, Wiebe DA, et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999; 100:1050-1055.
38. Agewall S, Wright S, Doughty RN, et al. Does a glass of red wine improve endothelial function? Eur Heart J 2000; 21:74-78.
39. Chou EJ, Keevil JG, Aeschlimann S, et al. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol 2001; 88:553-555.
40. Cuevas AM, Guasch V, Castillo O, et al. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers. Lipids 2000; 35:143-148.
41. Shimada K, Watanabe H, Hosoda K, et al. Effect of red wine on coronary flow-velocity reserve. Lancet 1999; 354:1002.
42. Freedman JE, Parker C III, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001; 103:2792-2798.
43. Keevil JG, Osman HE, Reed JD, et al. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000; 130:53-56.
44. Diebolt M, Bucher B, Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 2001; 38:159-165.
45. Djousse L, Ellison RC, McLennan CE, et al. Acute effects of a high-fat meal with and without red wine on endothelial function in healthy subjects. Am J Cardiol 1999; 84:660-664.
46. Duarte J, Perez-Palencia R, Vargas F, et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 2001; 133:117-124.
47. Benito S. Lopez D. Saiz MP, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 2002; 135:910-916. An interesting experimental study that demonstrated that the mechanism of increasing nitric oxide bioactivity was by increasing production rather than by decreasing breakdown.
48. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354:2048-2049.
49. Sherman DL, Keaney JF Jr, Biegelsen ES, et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000; 35:936-941.
50. Abou-Agag LH, Aikens ML, Tabengwa EM, et al. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res 2001; 25:155-162.
51. Iijima K, Yeshizumi M, Hashimoto M, et al. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation 2002; 105:2404-2410.
52. Kuiper GG, Carlssen B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138:863-70.
53. Makela S, Savolainen H, Aavik E, et al. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci U S A 1999; 96:7077-7082.
54. Hodges YK, Tung L, Yan XD, et al. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 2000; 101:1792-1798.
55. Darblade B, Pendaries C, Krust A, et al. Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 2002; 90:413-419.
56. Teede HJ, Dalais FS, Kotsopoulos D, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001; 86:3053-3060. A relatively large study of the effect of dietary soy on various cardiovascular risk factors and measures of vascular function.
57. Wiseman H, O'Reilly JD, Adlercreutz H, et al. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr. 2000; 72:395-400.
58. Squadrito F, Altavilla D, Squadrito G, et al. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 2000; 45:454-462.
59. Chin-Dusting JP, Fisher LJ, Lewis TV, et al. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br J Pharmacol 2001; 133:595-605.
60. Simons LA, von Konigsmark M, Simons J, et al. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000; 85:1297-1301.
61. Hale G, Paul-Labrador M, Dwyer JH, et al. Isoflavone supplementation and endothelial function in menopausal women. Clin Endocrinol (Oxf) 2002; 56:693-701.
62. Squadrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 2002; 163:339-347. Demonstrated that genistein improved vascular function in postmenopausal women.
63. Walker HA, Dean TS, Sanders TA, et al. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17 beta-estradiol. Circulation 2001; 103:258-262. This mechanistic study demonstrated that genistein, but not daidzein, acutely increased nitric oxide bioactivity in humans, and to a similar extent to that seen with estradiol.
64. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999; 84:895-898.
65. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328:1444-1449.
66. Duffy SJ, O'Brien RC, New G, et al. Effect of anti-oxidant treatment and cholesterol lowering on resting arterial tone, metabolic vasodilation and endothelial function in the human forearm: a randomized, placebo-controlled study. Clin Exp Pharmacol Physiol 2001; 28:409-418.
67. Beckman JA, Goldfine AB, Gordon MB, et al. Inhibition of protein kinase C-beta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 2002; 90:107-111.
68. Heitzer T, Herttuala SY, Wild E, et al. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol 1999; 33:499-505.